Clinical Trial Update: A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial for HIV vaccines LIPO-5 and ALVAC-HIV (vCP1452) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• ALVAC-HIV
• LIPO-5

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED